<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-KP3JBJ3R</identifier><date>2013</date><creator>Boc, Marko</creator><creator>Mesti, Tanja</creator><creator>Reberšek, Martina</creator><relation>documents/doc/K/URN_NBN_SI_doc-KP3JBJ3R_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KP3JBJ3R_001.txt</relation><format format_type="volume">17</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 139-142, 158</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">1682043</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KP3JBJ3R</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunomodulatorji</subject><subject language_type_id="slv">maligni melanomi</subject><subject language_type_id="slv">melanomi</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Imunomodulatorji pri zdravljenju malignega melanoma</title></Record>